Our client is seeking an experienced Application Developer to join its Global Life Office of the Customer team. This role offers the opportunity to develop and support business-critical applications ...
Develop, enhance, and maintain ERP applications using C# (.NET Core/.NET Framework) and Java. Work closely with business analysts and stakeholders to understand ERP system requirements and implement ...
Amazon Web Services (AWS), the cloud computing arm of Amazon, has said that artificial intelligence generated code does not automatically make software teams faster and can sometimes slow them down, ...
Jerry Lawson’s gaming system featured interchangeable cartridges, so users could swap out titles like “Space War” and “Math Quiz.” Illustration by Tuhina Sharma; Illustration reference: Liane Enkelis ...
Microsoft has cut off access to dozens of its open source projects hosted on GitHub as it investigates how hackers apparently breached the projects and injected password-stealing malware into the code ...
Apple stock's gains slipped away Monday afternoon as the iPhone maker kicked off his 15th Worldwide Developers Conference. The company showed off a new AI version of its Siri chatbot, technology ...
With Monday's keynote behind them, Apple developers at WWDC 2026 shifted into the hands-on phase Tuesday as Craig Federighi, the company's senior vice president of software engineering, fielded ...
Constellation Research CEO Ray Wang anticipates Apple's new AI strategies at WWDC, focusing on an updated Siri with potential multi-step functionality. This pivotal event introduces Apple's next ...
Today, Berkshire Hathaway has 227,917,808 shares, with a total market capitalization of $66.35 billion. It's still a sizable stake, accounting for 20% of Berkshire's portfolio, but that's a long way ...
Kyverna Therapeutics vs. Vertex Pharmaceuticals: Which Drug Developer Stock Is a Better Buy in 2026?
Kyverna Therapeutics operates as a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases. Its lead product candidate, KYV-101, is a CAR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results